Stockreport

Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025

Bioventus Inc. - Class A  (BVS) 
PDF DURHAM, N.C., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today a [Read more]